Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients.
Foegh
M L
ML
Department of Surgery, Georgetown University Hospital, Washington, DC 20007.
Lim
K
K
Douglas
F
F
Turk
J
J
Helfrich
G B
GB
Taher
S A
SA
Alijani
M R
MR
D003864:Depression, Chemical; D006084:Graft Rejection; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016030:Kidney Transplantation; D011725:Pyridines / Q000494:pharmacology* / Q000627:therapeutic use; D013929:Thromboxane B2 / Q000032:analysis*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D007093:Imidazoles; D007166:Immunosuppressive Agents; D011725:Pyridines; D013929:Thromboxane B2; C037787:pirmagrel; D013930:Thromboxane-A Synthase